Gray Kueberuwa

CEO at ImmunoKey

Speaker

Dr Gray Kueberuwa is CEO and Co-Founder of ImmunoKey, a UK biotechnology company developing next-generation CAR-T cell therapies for solid tumours. He has experience across the cell-therapy development pathway, including discovery research, intellectual property, process development, GMP manufacturing, regulatory interactions and clinical operations. He previously held leadership roles in a cell-therapy company that progressed through acquisition, international expansion and public-market financing.